Drug‐Drug Interaction Study of Apixaban with Cyclosporine and Tacrolimus in Healthy Volunteers
Open Access
- 3 July 2018
- journal article
- research article
- Published by Wiley in Clinical and Translational Science
- Vol. 11 (6) , 590-596
Abstract
Apixaban is metabolized by cytochrome P450 (CYP) 3A4 in the liver and intestine, undergoes direct intestinal excretion, and is a substrate to permeability glycoprotein (P‐gp) and breast cancer resistance protein (BCRP) transporters. We examined the drug interactions between cyclosporine and tacrolimus (combined inhibitors of CYP3A4, P‐gp, and BCRP) with apixaban in 12 healthy adult male volunteers. Apixaban 10 mg was administered orally alone, in combination with 100 mg cyclosporine or 5 mg tacrolimus. Co‐administration with cyclosporine resulted in increase in apixaban maximum plasma concentration (Cmax) and area under the plasma concentration‐time curve from time zero to the last quantifiable concentration (AUC(0‐tlast)) with associated geometric mean ratios (GMRs) and 90% confidence intervals (CIs) of 143% (112, 183) and 120% (97, 148), respectively. Co‐administration with tacrolimus resulted in reduction in apixaban Cmax and AUC(0‐tlast) with associated GMRs (90% CI) of 87% (69, 112) and 78% (63, 97), respectively. The observed changes in apixaban exposure margins with cyclosporine or tacrolimus are within the range of the historical clinical development program, therefore, apixaban dose adjustments are not warranted.Keywords
Funding Information
- Bristol Myers Squibb Foundation
- Pfizer
- National Institutes of Health (T32GM008562)
This publication has 31 references indexed in Scilit:
- Drug–Drug Interactions with the NS3/4A Protease Inhibitor SimeprevirClinical Pharmacokinetics, 2015
- Patients’ time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registryAmerican Heart Journal, 2015
- Atrial arrhythmias after lung transplant: Underlying mechanisms, risk factors, and prognosisThe Journal of Heart and Lung Transplantation, 2014
- Arrhythmias in the Heart Transplant PatientArrhythmia and Electrophysiology Review, 2014
- PharmGKB summaryPharmacogenetics and Genomics, 2013
- Effect of Cyclosporine on the Pharmacokinetics of Colchicine in Healthy SubjectsPostgraduate Medicine, 2012
- Membrane transporters in drug developmentNature Reviews Drug Discovery, 2010
- High Rate of Recurrence in Renal Transplant Recipients after a First Episode of Venous ThromboembolismTransplantation, 2005
- Mechanisms of Clinically Relevant Drug Interactions Associated with TacrolimusClinical Pharmacokinetics, 2002
- THE USE OF CYCLOSPORIN-A AND PREDNISONE IN CADAVER KIDNEY-TRANSPLANTATION1980